Cargando…
Single dose rasburicase in the management of tumor lysis syndrome in childhood acute lymphoblastic leukemia: A case series
Tumor lysis syndrome (TLS) occurs in malignancies with high proliferative potential and tumor burden, such as lymphomas and leukemias. TLS syndrome is an oncologic emergency, requiring prompt intervention. The metabolic derangements cause acute kidney failure and may lead to cardiac arrhythmias, sei...
Autores principales: | Latha, S. M., Krishnaprasadh, D., Murugapriya, P., Scott, J. X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379632/ https://www.ncbi.nlm.nih.gov/pubmed/25838646 http://dx.doi.org/10.4103/0971-4065.139092 |
Ejemplares similares
-
Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase
por: Alakel, Nael, et al.
Publicado: (2017) -
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy
por: Dinnel, Jennifer, et al.
Publicado: (2015) -
Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout
por: Cammalleri, Lisa, et al.
Publicado: (2007) -
Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia
por: Xue, Yao, et al.
Publicado: (2021) -
Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase)
por: Pession, Andrea, et al.
Publicado: (2008)